GL1X · GenesisL1 explorer

Research workbench

Protein kinase CK2 in complex with tetrabromobenzoimidazole K17, K22 and K32 inhibitors

Analyse Protein kinase CK2 in complex with tetrabromobenzoimidazole K17, K22 and K32… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2OXD
Type
protein
Length
325 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Casein kinase II subunit alpha
EC
2.7.11.1
UniProt
P28523
Ligands
K32
Pockets
3 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACasein kinase II subunit alpha (EC 2.7.11.1)protein32540% helix, 15% strandP28523

Ligands and binding sites

  • K32 · 4,5,6,7-tetrabromo-1H,3H-benzimidazol-2-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12990.670.8242K32
2560.330.7712empty
3560.260.7315empty

Compared structures

  • 2OXD · Protein kinase CK2 in complex with tetrabromobenzoimidazole K17, K22 and K32 inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • P28523 · AlphaFold monomer V2.0 prediction for casein kinase II subunit alpha (P28523) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.